MediWound Ltd.

General ticker "MDWD" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $201.6M (TTM average)

MediWound Ltd. does not follow the US Stock Market performance with the rate: -18.9%.

Estimated limits based on current volatility of 3.4%: low 13.33$, high 14.26$

Factors to consider:

  • Total employees count: 63 as of 2014
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [12.59$, 25.18$]
  • 2026-12-31 to 2027-12-31 estimated range: [12.21$, 24.61$]

Financial Metrics affecting the MDWD estimates:

  • Negative: with PPE of -8.9 at the end of fiscal year the price was high
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Positive: Interest expense per share per price, % of 0.31 <= 0.73
  • Negative: negative Net income
  • Positive: 42.59 < Shareholder equity ratio, % of 50.58 <= 64.29
  • Positive: -14.17 < Investing cash flow per share per price, % of -9.20
  • Negative: negative Industry operating cash flow (median)

Similar symbols

Short-term MDWD quotes

Long-term MDWD plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $18.69MM $20.22MM $16.96MM
Operating Expenses $34.19MM $39.60MM $42.24MM
Operating Income $-15.50MM $-19.38MM $-25.28MM
Non-Operating Income $8.97MM $-10.78MM $1.57MM
Interest Expense $0.34MM $0.56MM $0.66MM
R&D Expense $7.47MM $8.88MM $14.32MM
Income(Loss) $-6.53MM $-30.16MM $-23.71MM
Taxes $0.18MM $0.06MM $0.17MM
Net Income(Loss)* $-6.72MM $-30.22MM $-23.88MM
Stockholders Equity $31.59MM $31.15MM $43.63MM
Inventory $2.85MM $2.69MM $4.09MM
Assets $66.46MM $73.50MM $86.25MM
Operating Cash Flow $-10.46MM $-13.62MM $-14.53MM
Capital expenditure $6.46MM $6.27MM $5.50MM
Investing Cash Flow $-34.32MM $-8.40MM $-19.54MM
Financing Cash Flow $22.92MM $19.39MM $29.62MM
Earnings Per Share** $-0.75 $-3.03 $-2.10

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.